JPRN-UMIN000010266Completed未知
Assessment of efficacy and safety profile of irbesartan/amlodipine single-pill combination drug in uncontrolled-hypertension with type 2 diabetic patients. - Aimix study
Kanazawa Medical University Diabetes and Endocrinology0 sites50 target enrollmentStarted: March 18, 2013Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The exclusion criteria are based on fulfillment of at least one of the following; 1) a past history of allergy of this medicine or dihydropyridine drugs; 2) pregnancy, possibility of pregnancy; 3) current treatment with corticosteroids and/or immnosuppressive drugs; 4) patients who judge that the physician is not suitable
Investigators
Similar Trials
Recruiting
Not Applicable
Investigation of the safety and effectiveness of irreversible electroporation (IRE) using the NanoKnife® System in patients with unresectable stage 3 pancreatic cancer who have received 3 months of chemotherapy.Cancer - PancreaticPancreatic CancerACTRN12621000955819Walter & Eliza Hall Institute of Medical Research (WEHI)20
Recruiting
Phase 2
Clinical study on NR-INF-IB on skin in healthy participantsCTRI/2024/07/071054atural Remedies Pvt Ltd
Recruiting
Phase 2
Analysis of safety and efficacy parameters of indigenously asembled portable mini negative pressure wound therapy device in wound management .CTRI/2021/02/031120BIRAC
Completed
Not Applicable
ow cost Negative Pressure Wound Therapy device for the purpose of providing affordable health careCTRI/2019/01/017263Biotechnology industry research assistance council80
Completed
Phase 2
Prospective analysis of efficacy and safety of individualized administration of midazolam for sedation during bronchoscopyJPRN-UMIN000003971agoya University Graduate School of Medicine200